TrialThe oncologist2013

Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study.

Sandra M Swain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.